Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	82.88	23.36	14.47	14.22	32.94	12.6
Short-Term Investments	124.23	74.36	37.75	37.93	12.09	82.44
Cash & Short-Term Investments	207.12	97.72	52.23	52.15	45.02	95.03
Cash Growth	88.80%	87.11%	0.15%	15.82%	-52.62%	-26.48%
Accounts Receivable	-	-	-	-	3	-
Other Receivables	1.62	1.65	2.44	0.19	-	-
Receivables	1.62	1.65	2.44	0.19	3	-
Prepaid Expenses	2.21	1.14	0.73	0.42	2.38	2.71
Restricted Cash	0.34	0.34	0.34	0.34	5.89	-
Total Current Assets	216.13	100.85	55.74	53.1	56.29	97.74
Property, Plant & Equipment	14.42	7.98	7.99	11.07	21.74	18.35
Goodwill	-	-	-	-	-	32.47
Other Intangible Assets	-	-	-	-	1.38	1.5
Other Long-Term Assets	0.54	0.1	0.28	0.04	0.17	1.14
Total Assets	231.1	108.93	64	64.21	79.59	151.2
Accounts Payable	5.93	3.44	1.86	1.81	4.33	4.7
Accrued Expenses	6.89	6.33	5.99	3.99	5.59	3.41
Current Portion of Long-Term Debt	8.89	5.93	-	-	-	0.33
Current Portion of Leases	0.1	0.82	1	1.77	1.82	1.71
Current Unearned Revenue	-	-	-	-	-	0.3
Other Current Liabilities	0.04	0.06	4.58	0.2	4.9	31.52
Total Current Liabilities	22.18	16.59	13.42	7.78	16.62	41.96
Long-Term Debt	10.86	13.04	-	-	-	1.43
Long-Term Leases	4.25	3.26	4.4	5.85	7.56	5.26
Other Long-Term Liabilities	22.57	32.01	31.35	23.82	13.04	-
Total Liabilities	59.86	64.9	49.18	37.45	37.22	48.65
Common Stock	0.52	0.46	0.27	0.18	1.47	0.96
Additional Paid-In Capital	892.31	856.82	764.15	722.05	696.56	672.3
Retained Earnings	-721.62	-813.26	-749.52	-695.34	-655.64	-570.7
Comprehensive Income & Other	0.01	0.01	-0.07	-0.13	-0.03	-0.01
Shareholders' Equity	171.23	44.03	14.83	26.76	42.37	102.55
Total Liabilities & Equity	231.1	108.93	64	64.21	79.59	151.2
Total Debt	24.11	23.05	5.4	7.63	9.38	8.73
Net Cash (Debt)	183.01	74.67	46.83	44.52	35.65	86.3
Net Cash Growth	111.35%	59.47%	5.17%	24.90%	-58.70%	-28.86%
Net Cash Per Share	2.98	1.82	2.19	5.66	9.05	23.28
Filing Date Shares Outstanding	54.19	48.53	27.36	17.71	5.9	3.95
Total Common Shares Outstanding	52.4	45.64	26.52	17.72	5.89	3.85
Working Capital	193.95	84.27	42.32	45.32	39.67	55.78
Book Value Per Share	3.27	0.96	0.56	1.51	7.20	26.67
Tangible Book Value	171.23	44.03	14.83	26.76	40.98	68.59
Tangible Book Value Per Share	3.27	0.96	0.56	1.51	6.96	17.84
Machinery	13.07	9.98	7.92	9.02	10.98	9.98
Construction In Progress	5.02	0.62	-	-	3.22	0.07
Leasehold Improvements	8.6	8.81	8.6	8.61	8.6	8.6

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.